Stay updated on Clinical Trial: Benfotiamine in Alzheimer's Disease
Sign up to get notified when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.

Latest updates to the Clinical Trial: Benfotiamine in Alzheimer's Disease page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe ClinicalTrials.gov record for the benfotiamine Alzheimer’s disease pilot study is displayed, with its completed-study status, design, participation criteria, outcome measures, and published results. It also includes a study protocol and statistical analysis plan document.SummaryDifference53%

- Check19 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov revision as v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about replacing “Artificial Intelligence” with “Super Intelligence” under Executive Order 14434.SummaryDifference1%

- Check33 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1. The study page itself remains a 403 error page.SummaryDifference0.2%

- Check40 days agoChange DetectedThe site’s footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, restricting access to the entry and its details. Navigation and site chrome remain visible, but the study content is inaccessible.SummaryDifference19%

Stay in the know with updates to Clinical Trial: Benfotiamine in Alzheimer's Disease
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.